At NINGBO INNO PHARMCHEM CO.,LTD., we recognize the intricate science behind drug development, and understanding metabolites is a critical component. N-Benzoyl-DL-tyrosyl-N',N'-dipropylamide (BTP), identified by CAS 57227-09-5, plays a significant role in this area as a recognized metabolite of the antispasmodic drug Tiropramide. This designation means that BTP is a substance produced when the body processes Tiropramide, making it a key focus for researchers studying drug pharmacokinetics and metabolic pathways.

For pharmaceutical companies and research laboratories, having access to reliable standards of known metabolites is essential. N-Benzoyl-DL-tyrosyl-N',N'-dipropylamide serves precisely this purpose. It allows scientists to accurately identify and quantify the presence of this metabolite in biological samples, which can provide crucial insights into how a drug is absorbed, distributed, metabolized, and excreted by the body. This knowledge is fundamental for determining optimal drug dosages, understanding potential drug interactions, and ensuring patient safety. When professionals search for 'N-Benzoyl-DL-tyrosyl-N',N'-dipropylamide uses', its application in metabolite analysis is a primary consideration.

The availability of high-purity N-Benzoyl-DL-tyrosyl-N',N'-dipropylamide from various N-Benzoyl-DL-tyrosyl-N',N'-dipropylamide suppliers supports these critical research efforts. Whether it's for developing new analytical techniques or conducting extensive metabolic profiling, a consistent and quality supply is necessary. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing the chemical building blocks and standards that drive innovation in pharmaceutical research. The study of metabolites like BTP is a testament to the comprehensive approach required to bring safe and effective new drugs to market.